SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " seed " 611 found 🔀 AI-powered Shuffle
Corteva Board Approves Seed Business Spinoff as Vylor
Corteva (NYSE:CTVA) said its board has approved the separation of the company’s seed operating segment into an independent, publicly traded company named Vylor Inc. Vylor is expected to list on the New York Stock Exchange under the ticker symbol VYLR following completion of the separation.
Scientists Identify The 'Doomsday' Seeds That Could Last The Longest
Some not-so-great news for the diet of the future...
Health department officials confirm ricin found in Hastings apartments
Officials said testing confirmed the substance found in a now-shuttered Hastings apartment complex was ricin, a potentially deadly toxin.
Albert Breer Has Broncos Making The Super Bowl
Fueled by a blockbuster trade for Jaylen Waddle and Bo Nix’s return, Denver eyes a championship run after Albert Breer projected the AFC’s top seed to reach Sunday’s biggest stage.
GB's Hewett beats Oda to win fifth US Open title
Great Britain's Alfie Hewett beats Japanese top seed Tokito Oda to win a fifth US Open title and his 11th Grand Slam singles crown overall.
US Open Final Preview: Ben Shelton Faces Alexander Zverev for New York Glory
And then there were two, as after almost a fortnight of high-octane tennis at the US Open, we have a final set, as the No. 1 seed Alexander Zverev is set to face off against the No. 1 American men’s player, Ben Shelton. The two players have separated themselves from the others over the course …
US Open news: Ben Shelton to face Alexander Zverev in Singles Finals
Ben Shelton is one win away from ending 23 years of waiting for American men’s tennis. The No. 8 seed outlasted good friend and fellow American Frances Tiafoe 4-6, 6-3, 6-3, 7-5 on Friday at Arthur Ashe Stadium to reach his first career Grand Slam final, where he will meet top seed Alexander Zverev on Sunday with the US Open title on the line. The […] The post US Open news: Ben Shelton to face Alexander Zverev in Singles Finals appeared first on ClutchPoints.
US Open: Ben Shelton takes down Frances Tiafoe to seal Alexander Zverev showdown in final on Sunday in New York
Ben Shelton wins all-American duel with Frances Tiafoe to set up US Open final with top seed Alexander Zverev on Sunday; watch the US Open womens final live on Sky Sports Tennis and Sky Sports+, streaming service NOW and the Sky Sports app on Saturday
Dodgers’ Magic Numbers Shrink After Huge Night in NL Standing
The Dodgers' magic number for the NL West and the No. 2 seed in the NL shrank after their win and the Braves' loss.
Scientists unlock secrets of ancient Egyptian materials with proteomics
Analysis revealed seed proteins from sesame and moringa, which held religious and symbolic significance.
New business incubator aims to transform North Lake Charles
A new business hub is coming to north Lake Charles, aiming to give local entrepreneurs a hyper-local launchpad for success. “We already have the McNeese SEED Center, which is a […]
Wilmington health tech founder launches new venture
Several years after launching his health tech startup Artemis Immersive, founder Adam Isley is setting his sights on new horizons. Co-founded in 2023 by husband-and-wife Adam Isley and Kaylan Barbrey, along with Matthew Raffa and Bill Blakesley, Artemis Immersive began as a spatial medtech company that created digital renderings of medical scans for viewing in augmented reality (AR). Isley said the firm, which won an NC Tech award in the Biotech + HealthTech Innovation category last year, has raised $1.2 million in total in seed funding since launching. Isley has since created a new venture, Research and Me, building on the Artemis platform. Like Artemis Immersive’s core software, VoxScan, Research and Me combines health data with artificial intelligence in a 3D interactive environment to help patients better understand health outcomes and provide integrative wellness support. While the Artemis product is no longer Isley’s primary focus, he said the company’s technology and ambitions have evolved into different ventures, like Research and Me. "It's a different venture building on the Artemis platform, and there'll probably be more,” Isley said. He added, "I was very disappointed in the quality of the information available to general patients about their healthcare... I wanted to give patients more and a better plate of choices." Research and Me is still in its beta phase, Isley said, with usability testing ongoing in partnership with the firm’s partner, Medicap Pharmacy and Wellness Center, owned by Barbrey. "As someone who's kind of dedicated their life to working in healthcare, I've tried to bring this spirit and passion to it,” he said, “and a lot of the resources that we'll be providing are free — like a base level of free care for any patients, or medical education if they've got specific conditions." Isley describes Research and Me as a “patient-first” platform designed to securely store and pseudonymize health data and use AI and medical literature to generate insights. The insights are presented in an interactive 3D environment for patients and providers to explore conditions, treatments and wellness plans together. "It's almost like a democratization of understanding medical information," Isley said. "We take a whole bunch of clinical data, we take a whole bunch of peer‑reviewed, published studies on PubMed, and we try to turn them into chunks of information that normal humans can understand." Like VoxScan, the Research and Me platform lets users interact with 3D anatomical models for visualization. The platform provides a space for tracking, notes and insights. The platform also supports video conferencing, Isley said, allowing providers or coaches to examine models and data together. "We wanted to create a safe environment where you can start to learn and experiment with new features about your health, using agents to do that,” Isley said. While Research and Me is in beta-phase testing with Medicap Pharmacy, Isley said he envisions the platform serving a wellness-oriented community, working with sports performance clinics and hormone optimization. Isley, who is working towards a wellness-coach board certification, also plans to offer functional wellness consults through the platform. Long‑term, Isley says he wants the platform to embody an “integrative health practitioner” approach, “connecting experts of different fields and specializations in a way that they can make a greater impact in people's lives.” “For people in the state of North Carolina, it's already a win,” Isley said of the Medicap rollout, noting that partner clinics get “immediate resources for learning about their health and wellness conditions… out of the box.” Isley plans to launch Research and Me’s provider portal in 2028 and begin pursuing integrations with larger systems, he said.
9 Foods With More Fiber Than a Pear
Pears aren’t the only food packed with fiber. Foods like chickpeas, raspberries, and chia seeds contain even more fiber than a pear.
Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform
Senphonix, Inc., a medical-technology startup developing SleeveSense™, a wearable that will continuously monitor patients' vital signs over days, weeks, or months, today announced it has received a Small Business Technology Transfer (STTR) Phase I award from the U.S. National Science Foundation (NSF) through America's Seed Fund. The award supports engineering to strengthen the patent-pending device's wireless and radio-frequency systems and to move it from prototype toward a manufacturable produ
The best way to eat flaxseed
To get the full health benefits from flaxseed, there’s a certain way experts recommend eating it.
Apple Seeds iOS 27 and iPadOS 27 Release Candidates
Apple today seeded the release candidate versions of iOS 27 and iPadOS 27 for final testing purposes, with the update coming a week after Apple released the eighth betas. These will be the last beta updates of iOS 27 and iPadOS 27 before the software's public release, as long as no bugs are found. Registered developers and public beta testers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update.
macOS Golden Gate Release Candidate Now Available
Apple today seeded the release candidate version of macOS Golden Gate, with the update coming a week after Apple seeded the eighth beta. The release candidate is the final version of macOS Golden Gate that developers and beta testers will get before the software sees a public launch. Tessters can download macOS Golden Gate by going to System Settings > General > Software Update. Beta Updates will need to be enabled, and a free developer account is required.
The Marvel of a Seed
Growth of the ID movement has occurred through “sowing the seeds” of evidential support for the theory.
Jessica Pegula rallies back into U.S. Open semifinals
BUFFALO, N.Y. (WIVB) — Jessica Pegula came back to win her U.S. Open quarterfinal match Tuesday night at Arthur Ashe Stadium, reaching the semifinals of the Grand Slam event for the third year in a row. Pegula, the 32-year-old Buffalonian ranked No. 3 in the world, defeated No. 26 seed Emma Navarro in the all-American […]
Realistic Detroit Pistons Expectations For 2026-27 Season
The Detroit Pistons made a lot of changes during the offseason, but how will that impact their quest to retain the top seed in the Eastern Conference?
In 2018, scientists seeded clouds over China's Muz Taw Glacier to make snow; the brighter surface was followed by 14% to 17% less ice loss in a preliminary experiment
Researchers in China have tried to make artificial snow over China’s Muz Taw Glacier to slow its melting. The experiment conducted in 2018 involved seeding clouds with silver iodide, which helped trigger snowfall over the glacier.
Zverev eases into US Open quarter-finals
Top seed Alexander Zverev has reached the quarter-finals of the US Open to become the only man to reach the last eight at all four Grand Slams this year. The French Open winner advanced after a 6-2, 6-2, 7-6 (7-3) win over Italy's Luciano Darderi on Monday evening.
Where Atlanta Hawks Should Finish in Loaded Eastern Conference
The Atlanta Hawks could contend for a top-four seed in 2026-27, but a dramatically reshaped Eastern Conference gives them plenty of competition.
Seedy K’s GameCap: Ole Miss
Last night’s was the first Cardinal football game since The Professor passed away. He loved college football. He loved the U of L Cards. His spirit force was strong with me during last night’s opener, a self inflicted 38-41 L to Ole Miss in the Music City Something or Another in NashVegas. Specifically felt his […]
Defending champion Sabalenka reaches US Open quarter-finals
World number one Aryna Sabalenka led the way into the US Open quarter-finals, subduing American Taylor Townsend in straight sets on Sunday to keep her bid for a rare three-peat on track.Sabalenka rallied from 3-1 down in the second set for a 6-4, 6-3 victory on Arthur Ashe Stadium, where men's defending champion Carlos Alcaraz took on 20th-seeded American Tommy Paul in search of a quarter-final berth.
The One Seed Dietitians Recommend for Brain, Heart, and Gut Health
Chia seeds top dietitians’ picks for brain, heart, and gut health thanks to fiber, ALA omega-3s, and antioxidants, with flaxseed close behind.
Alaska Science Forum time capsule: Stalwart perennials make a bet on the future each year
Their game has only a few simple rules. Grow as fast as you can, bloom and set seeds to continue the line, and stash away every spare crumb of energy you can to get through the winter.
Swiatek into US Open fourth round in tight two-setter
Six-time Grand Slam champion Iga Swiatek reached the US Open fourth round on Saturday with a tight two-set victory over Czech Maria Bouzkova.Poland's Swiatek, seeded eighth as she seeks to cap an erratic season with a second US Open crown, dominated both tiebreakers in a 7-6 (7/3), 7-6 (7/3) victory over 25th-seeded Bouzkova, who broke Swiatek early in each set but couldn't make the lead stand up.
Alexander Zverev Has a Highway to the US Open Semifinal
The bracket gods have been extraordinarily generous to Alexander Zverev at the 2026 US Open. Lorenzo Musetti, who held a 3-2 head-to-head advantage over him and was seeded 13th, went out to Australian wildcard Dane Sweeny before they could meet. Alex de Minaur, the sixth seed and one of the most annoying players to play …
El Camino College launches business competition for aspiring entrepreneurs
El Camino College is launching a Launch & Grow Your Business program, offering up to $4,000 in seed money for budding entrepreneurs.
PRIMA raises $5M to turn hot tables into a referral business
Miami-based PRIMA wants to change that. The hospitality booking platform has raised a $5 million seed round to expand its performance-based referral network
Caltech and KAIST Establish Program to Co-Mentor Tomorrow's Chemists and Drive Future Discoveries
Chemists from the two institutions will work together to identify projects and then mentor postdocs and host graduate students, enabling researchers to experience multiple environments while seeding additional collaboration
Where Indiana lands in ESPN’s 2026 College Football Playoff predictions
Here’s where ESPN’s panel of experts projects the Hoosiers land in the 2026 College Football Playoff seeding.
Madison Keys Saves Five Match Points to Survive Anna Bondar
Madison Keys produced the escape act of the US Open so far, clawing back from 5-2 down in the third set and fending off five match points before outlasting Anna Bondar 5-7 6-4 7-6(5) in a second-round thriller that had Court 17 on its feet. The 22nd seed and former Australian Open champion looked in …
Birds stop play but Medvedev flies into third round
An interruption from a pair of birds ruffles Daniil Medvedev's feathers but fails to disrupt the seventh seed as he eases into the US Open third round with a dominant victory over Sebastian Gorzny.
The Most Shocking Upset of the 2026 US Open First Round Isn’t the One You Think
Yes, Novak Djokovic lost in the first round of the US Open. A 39-year-old playing his first Grand Slam match on hard in months, seeded fourth on his reputation more so than his form, went down against Mariano Navone over four hours and 36 minutes and ended a run of 84 consecutive Grand Slam wins …
Dozens of Nashville businesses appeal property value as state leaders prioritize tax cap
Fox 17 provides local news, weather, sports, traffic and entertainment for Nashville and nearby towns and communities in Middle Tennessee, including Forest Hills, Brentwood, Franklin, Fairview, Dickson, Clarksville, White House, Greenbrier, Springfield, Gallatin, Hartsville, Lebanon, Mt Juliet, Smyrna, College Grove, Thompson’s Station, Centerville, Murfreesboro, Columbia, Lewisburg, Shelbyville, Manchester, McMinnville, Smithville, Sparta, Cookeville, Hohenwald, Waverly, Camden, Paris, Lafayette, Portland, and in Kentucky, Russelville, Bowling Green, Franklin, Alvaton, Scottsville, Hopkinsville, Glasgow.
Apple Releases New iOS 27, iPadOS 27, macOS 27, and tvOS 27 Public Betas
Apple today released the sixth public betas of iOS 27, iPadOS 27, tvOS 27, and macOS Golden Gate, allowing anyone with a compatible device to download and test the new software. The sixth betas come a week after Apple seeded the fifth betas and a few hours after the eighth developer betas. You can get started by signing up on Apple's beta website and then opting in to the public beta by opening up the Settings app on your device, selecting General, and choosing Software Update.
Apple Releases macOS Golden Gate Beta 8
Apple today provided developers with the eighth beta of macOS Golden Gate, with the update coming a week after Apple seeded the seventh beta. Developers can download macOS Golden Gate by going to System Settings > General > Software Update. Beta Updates will need to be enabled, and a free developer account is required. macOS Golden Gate includes multiple design improvements.
Apple Seeds Eighth iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the eighth betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming one week after Apple released the seventh betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Tulane Ventures brings behavioral health company to New Orleans
Tulane Ventures has invested $250,000 in Cabana, a behavioral health platform co-founded by a Tulane alumnus, as part of a $1 million seed round that also includes 1834 Ventures.Cabana combines clinical care, community groups and tech-enabled support to embed behavioral health support — outside of medical appointments — in the lives of patients battling physical ailments.
Nashville mayor proposes business grants as high costs continue to challenge city staples
Nashville's Mayor is proposing grants and incentives for small and longstanding businesses as costs continue to rise, but many opponents prefer property tax cut
Scientists Analyzed Earth's Hidden Seed Vaults And Made a Disturbing Realization
You reap what you sow.
Apple Seeds Seventh iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the seventh betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming one week after Apple released the sixth betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Behind the Garden Trails: Science Protecting the Sonoran Desert
As changing weather reshapes desert ecosystems, the Garden’s research team is studying how native plants respond to extreme heat, prolonged drought and shifting weather patterns.
AI Live Entertainment Financial Platform Quantizr Raises $5M
Quantizr, an AI-powered 'financial command center' built with live music in mind, has announced a $5 million seed round.
Apple Accidentally Leaked More Than 10 New Products in macOS Update
Apple on Monday seeded the macOS 26.7 Release Candidate, and the upcoming software update has seemingly leaked more than 10 new Apple products. macOS 26.7's code contains references to AirPods with infrared cameras for Visual Intelligence, the long-rumored foldable iPhone, an all-new Apple smart home hub, the first-ever MacBook and iPad mini models with OLED displays, an updated Siri Remote for a next-generation Apple TV, and more, according to MacRumors contributor Aaron Perris.
Plant Breeding's Future Depends on More Than Science
The future of plant breeding needs more than technical skill. Ana Maria Heilman-Morales explains why mentorship, service and courage matter.
macOS Tahoe 26.7 is Full of References to Unreleased Apple Products
The macOS Tahoe 26.7 release candidate that Apple seeded today has references to several unreleased products, from home devices to iPhones, iPads, AirPods, and Macs. Some of these codenames have shown up in prior software updates but have new feature flags, while others haven't been seen in the code before.
Apple Releases New iOS 27, iPadOS 27, macOS 27, and tvOS 27 Public Betas
Apple today released the fourth public betas of iOS 27, iPadOS 27, tvOS 27, and macOS Golden Gate, allowing anyone with a compatible device to download and test the new software. The fourth betas come a week after Apple seeded the third betas and just a few hours after the sixth developer betas. You can get started by signing up on Apple's beta website and then opting in to the public beta by opening up the Settings app on your device, selecting General, and choosing Software Update.
Apple Seeds Sixth iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the sixth betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming one week after Apple released the fifth betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Seedy foreign money shaping culture, politics
More than any political cycle in memory, the 2026 primary campaign season has been marked by frequent, and often hysterical, condemnations of the influence of the so-called “Israel lobby.” After the conspiratorial anti-Trump gadfly Rep. Thomas Massie (R-Ky.) lost his Republican congressional primary in northern Kentucky in May, he quipped about the Trump-endorsed former Navy […]
The Scientists Who Want to Steer Hurricanes
Over the weekend, Hawaii was lashed by Hurricane Lala, which has washed away homes, left more than 125,000 people without power, shut down two of the state’s busiest airports, threatened dangerous flash flooding and, at time of writing, has killed one person. What if we could’ve steered the storm away from Hawaii, into the vast expanse of the empty Pacific Ocean that lies all around the islands—where no one could get hurt? This scenario might sound like the stuff of science fiction. But earlier this year, a peer-reviewed study published by the Public Library of Science found that it might be possible, and sooner than we think. The study was titled: “Weather Jiu-Jitsu: Prospects for atmospheric nudging to defuse the impact of catastrophic weather extremes.” According to the paper, the controversial practice of cloud seeding could enable human beings to make hurricanes change direction. The potential results could be astounding: The authors suggested that Hurricane Sandy, which in New York City alone killed 44 people and caused $19 billion of damage in 2012, could’ve been diverted by 200 miles, missing the metropolis entirely. Cloud seeding, which first succeeded in the U.S. in 1946, is a practice whereby small particles—for example, dry ice, silver iodide, or salt—are dropped into clouds, causing moisture to condense into precipitation. In the 1960s, the U.S. government launched Project Stormfury, an experiment that saw Navy pilots flying into the heart of a hurricane, dodging winds over a hundred miles per hour, to cloud-seed inside it, in the hope of reducing the storm’s power. “The seeding,” the theory went, “would stimulate the formation of a new eyewall that would surround the existing eyewall. The new eyewall would contract, strangling the old eyewall and reducing the intensity of the hurricane.”
Two Major Stretches Potentially Determining Orlando Magic's Season
A daunting January gauntlet and late-season road trip force Orlando to prove their championship mettle. Success hinges on dominating a crucial homestand to secure vital playoff seeding.
Triangle Group Raises $15 Million To Scale Asia-Pacific Live Entertainment Platform
Triangle Group has raised $15 million in equity and venture debt to expand its live touring and festival infrastructure across Asia-Pacific. The financing consists of a $10 million equity seed round led by DSG Consumer Partners, with participation from Golden Gate Ventures, the Oberoi Family Office, and angel investors, along with a $5 million venture debt facility from Genesis Alternative Ventures.
The surprising health benefits – and one drawback
Despite their small size, sesame seeds are remarkably nutrient-dense.
Third iOS 27 and iPadOS 27 Public Betas Now Available
Apple today released the third public betas of iOS 27 and iPadOS 27, allowing anyone with a compatible device to download and test the new software. The third betas come two weeks after Apple seeded the second betas. You can get started by signing up on Apple's beta website and then opting in to the public beta by going to Settings > General > Software Update and choosing the iOS 27 or iPadOS 27 Public Beta option.
2026 College Football Playoff bracket projection: Notre Dame, Georgia take top seeds
See CBS Sports' full 2026 College Football Playoff projections, including the 12‑team field, first‑round matchups, quarterfinal picks, semifinal results and a national championship prediction
Seedy K’s Preseason Prattle: Oligarchs, Senators & Cards’ Greatest Villain
The oligarchs who run college football met this week to begin to perhaps decide the future of the sport. How to maximize revenue. Especially for the oligarchiest among them, Big Ten, SEC and that school Paul Hornung attended. They met virtually. Though the meeting was originally set for the new Four Seasons Resort at Del […]
Spanish teen Jodar ousts eighth seed Lehecka at Montreal
Spanish teen Rafael Jodar defeated Czech eighth seed Jiri Lehecka 6-3, 6-3 on Saturday to reach the quarter-finals of the ATP Montreal Masters.Jodar will play for a semi-final berth against French 18th seed Arthur Fils, who defeated Britain's Cameron Norrie 6-2, 7-6 (10/8).
Top-ranked Sabalenka, Pegula stunned in Toronto fourth round
World number one Aryna Sabalenka and Jessica Pegula were both upset in fourth-round matches on Saturday at the Toronto Masters.Russian 15th seed Shnaider upset world number three Pegula 6-3, 6-3 to book a last-eight date with Poland's Iga Swiatek.
World number one Sabalenka ousted in Toronto by Alexandrova
World number one Aryna Sabalenka was eliminated by Russian 16th seed Ekaterina Alexandrova on Saturday in a fourth-round match at the WTA Toronto Masters tournament.Sabalenka, who will seek her third consecutive US Open title next month, fell to 5-5 in her career WTA rivalry with Alexandrova, who will face either American eighth seed Amanda Anisimova or Ukraine's ninth-seeded Elina Svitolina in the quarter-finals.
Seedless and WatermelonDS Drop Their Latest Updates at Once
The world of Nintendo DS emulation has always been a bit of a strange thing. You're either in the camp where the emulation is fine, or the one where it's just better to do it on an original console. Recently though, those lines have been blurred with dual screen releases like the Anbernic RG DS,
No.1 Sabalenka and Pegula advance at Toronto
Top-ranked Aryna Sabalenka advanced to the fourth round of the WTA Toronto Masters on Thursday by defeating China's Zhang Shuai 6-3, 6-4.American third seed Jessica Pegula advanced to the round of 16 by defeating Uzbekistan's Kamilla Rakhimova 6-4, 6-0 in 68 minutes.
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Seeds Rybakina, Pegula and Gauff advance at WTA Toronto event
Second seed Elena Rybakina, third seed Jessica Pegula and fourth-seeded Coco Gauff advanced to the third round of the WTA 1000 tournament in Toronto on Wednesday.Rybakina hit back-to-back double faults to drop the second set and three double faults while serving for the match before advancing to next face 28th-seeded American Ann Li, who eliminated Canadian wildcard Kayla Cross 7-6 (7/2), 6-3.
Ted Leonsis co-founded Proxy Foods AI raises $6M
D.C. startup Proxy Foods AI raised $6 million in seed funding led by Ted Leonsis to expand its artificial intelligence platform for recipe development.
Superheated magma may power towering lava fountains
Scientists studying magma from the 2021 Tajogaite eruption on La Palma have discovered that extreme heat can dramatically change how an eruption unfolds. When magma becomes superheated, it can dissolve the tiny crystal seeds that normally trigger crystallization, allowing the molten rock to remain fluid far longer as it rises.
Next Week on XBOX: New Games for August 3 to 7
Next Week on XBOX: Beast of Reincarnation, Kynseed, Montabi, and more coming soon!
Does public health *need* MAHA?
Last week, our friend Dr. Craig Spencer sparked an ongoing volatile discussion with his Atlantic article “Public Health Needs MAHA.” Some have come out in strong dissent, others are cheering, and others are simply lamenting that we find ourselves in such a divided world to begin with. We will dare to dip our toes in these controversial waters, too. Does public health need MAHA? We think in some ways yes, and in other ways, no. MAHA leaders versus the everyday MAHA supporter The vitriol in this debate mostly comes from one collapsed distinction: the leadership of MAHA is not necessarily the same as the people who support it. Say “MAHA” and most people picture RFK Jr. Fair enough, as he coined the term and holds most of the power. And, yes, some MAHA followers treat Kennedy as something close to a saint. But talk to the grassroots, and it’s not a monolith. They’re Republicans, Democrats, and Independents. People who distrust vaccines and vaccine supporters. It’s a wide, eclectic coalition. The data backs this too: 4 in 10 Americans support the movement—that’s a lot of people! But according to polls, vaccines and medical choice (the issues most tied to Kennedy personally) are cited by only 4% as their reason for supporting the movement. For many, the motivations are much broader. Many MAHA supporters are signing up for the idea that “something needs to change” with health in this country. They’re asking good-faith questions about corporate influence on our health systems, health care costs, nutrition, chemicals, and clean air and water. These are all questions that plenty of public health professionals recognize as legitimate and also care about very deeply. Blurring the lines between the leadership and grassroots does real damage in two important ways: It hands the 4 in 10 exactly the narrative already fed—that the health ecosystem doesn’t listen, doesn’t care, and paints every critic with the same brush. It gives the actual bad actor more power. RFK Jr. has done irreparable damage and can’t be trusted. What the MAHA movement gets right A healthy population is something the public health field was literally built on, and many of these topics are things we have dedicated our lives to. Yet the MAHA movement has captivated nearly half the country in a way the public health establishment has failed to achieve. So that means MAHA is doing something right. Some of it may be timing (after a Covid-19 pandemic and deep frustration and mistrust with institutions). The movement also does three other things really well: 1. It gives a new, louder voice to system failures. While MAHA is not a monolith, one theme stays consistent across their stories: the system failed them. For some, it was the system that flooded their communities with opioids and then walked away. For others, it was the system that let their business collapse during Covid with no safety net in sight. For others still, it was the system that failed to help them manage a complex chronic illness, bouncing them from physician to physician without any real answers. And in many ways, our health ecosystems are failing Americans. Why are medical bills so incomprehensible? Why do some kids get a healthy school lunch and others don’t? Why do an epidemiologist and a MD/PhD student have to start newsletters in the middle of the biggest public health emergency in a century, just so people can get straight information? Because the systems failed. This deep-seated frustration driving many Americans to search for solutions elsewhere needs to be recognized. 2. MAHA has brilliant comms central to their efforts. MAHA figured out something most health institutions still have not: the information landscape changed. It’s participatory now, not top-down; influence runs through many nodes in a community, not one institution; and storytelling and telling audiences “what you really think” moves people more than data dumps do. MAHA goes where audiences are listening, using podcasts, social media, and memes in ways most health institutions would scoff at—but it works. 3. They are very good at organizing. A MAHA meeting feels like a rally: energy, speakers, music, and most importantly, an action for everyone. Someone’s writing the next policy brief, someone’s seeding a narrative, someone knows the next legislative deadline, someone’s sending the text messages for a campaign. None of this is new (ask the civil rights movement), but MAHA knows it works and has capitalized on it. What MAHA gets wrong This list could be much longer, and this newsletter has spent a lot of time covering it, but here are a few things: Poor use of scientific evidence. This is the fundamental problem with many MAHA policies: the hype outpaces the science, and experts are often villainized for pointing this out. MAHA leadership has traded real solutions for cheap wins. For example, instead of taking on the powerful food industry and passing real reforms, it has celebrated french fries made of beef tallow and taken out artificial dyes from still very sugary children’s cereal. These changes won’t move the needle on America’s diet. MAHA leadership has tried to dismantle vaccine access in the U.S. While many MAHA supporters emphasize other issues, the effort to change vaccine policy has become MAHA’s signature effort. This is not surprising given RFK Jr.’s extensive track record campaigning against vaccines. It has rallied behind the wrong leader. RFK Jr. has a decades-long track record of villifying doctors, scientists, and public health workers, well before he became HHS secretary. He is known for his decades-long work sowing distrust in vaccines as well as life-saving treatments like antiretroviral therapy for HIV. This is not a serious person who can move the needle on health in the U.S, and he has already done serious damage. Public health needs more than defense Defending the evidence is absolutely necessary so health in the U.S. doesn’t move further backward. The public health establishment is very good at defense. The problem is this defense often sounds like defending the status quo, which has failed many people. Public health needs to offer an alternative to RFK Jr.’s MAHA—one that is rooted in evidence, truly listens to and addresses people’s frustrations, and has innovative solutions and the courage to change the systems. How do we get there? Find common ground. Do you know what most people care most about? The abysmal cost of healthcare. Start there. Fight for the human loudly. Too often, communications and engagement center on science with a capital S, funding mechanisms, or the CDC/FDA/NIH. Not the person. So the public doesn’t see themselves in it. Instead, they see people fighting for the very powerful systems that they feel negatively impact their health and well-being. Let the public feel and hear that you see their frustrations, you get it, and you’re fighting for them within the system. Recognize when pro-science messages are alienating people. Facts absolutely matter, but angrily venting only alienates people further. Our friend Elisabeth Marnik recently wrote a New York Times article about her experience growing up unvaccinated and how listening and empathetic conversation are the only ways to reach people that really work (a position backed by communication science). Her comments section was full of hateful comments from pro-vaccine individuals attacking her for daring to suggest we approach vaccine-hesitant individuals with empathy. It is possible to both stand firm behind scientific evidence and empathize with people who don’t trust it. Lean into politics smartly. Often, public health has shied away from politics: Don’t touch it, lest you get burned. But this fails to recognize that the third rail is what fuels the train: who is elected determines our budgets, our priorities, and our authority. Being political means being very savvy in strategy on both sides of the aisle, knowing your audience, and recognizing that political capital is as scarce as financial resources and needs to be allocated accordingly. Bottom line So does public health need MAHA? That’s not really the right question. Public health has a responsibility not to dismiss 40% of the country who feel heard by this movement and are frustrated that the system has failed them. And it has a responsibility to stick to the evidence and recognize MAHA leadership for what it is: a danger to our nation’s health. Both can, and should, be done. Love, YLE and KP A big thanks to Craig Spencer, who had the courage to put his neck out there to start a much-needed discussion at such a critical moment—one that is determining the identity of an entire field. Kristen Panthagani, MD, PhD is completing an emergency medicine residency and research fellowship focusing on health literacy and communication. In her free time, she writes the newsletters You Can Know Things debunking health myths and rumors and The Public Health Roundup. Views expressed belong to KP, not her employer. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Huck Institutes announces recipients of nine interdisciplinary seed grants
Penn State’s Huck Institutes of the Life Sciences has awarded nine research teams seed funding for 2026-27. These grants support high-impact, innovative research projects that align with the Huck’s strategic research priorities and have the potential to drive scientific breakthroughs and generate significant return on investment.
Europe got its own TBPN-style live show, and everyone’s angling for a guest spot
On Monday, the network announced a $1.6 million seed round from top players in the media ecosystem, including Powerhouse Capital, Axel Springer SE (which owns Business Insider and Politico), the popular media publication LadBible, and angel investors from OpenAI and DeepMind. With this fresh capital, the network is announcing its largest expansion yet.
Seedy K’s Ville Report: La Familia III
For reasons soon to be explained, this can’t be called a GameCap. I had every intention of covering it normally. Running box score on the MacBook. Notepad in hand. Then, at 4:52, I got a call from my ex-, with whom I’m better friends than ever. Even when we were together. It was granddaughter — […]
Will Jared Goff Contend for NFL MVP in 2026?
If the Detroit Lions win the NFC North, earn the No. 1 seed, and Jared Goff posts another outstanding statistical season, he could emerge as a legitimate NFL MVP candidate.
Hospital food gets a healthy makeover from celeb chef: 'Food is medicine'
After three years of rethinking hospital meals, Michelin star chef Geoffrey Zakarian is swapping boxed shakes, seed oils and sugar for fresh comfort food, smoothies and protein-rich dishes built around the idea that food can help with healing.
Snapseed Camera adds geotags & saving originals on Android
Another update for the Snapseed Camera on Android this month introduces location metadata and support for saving the original image.
Apple Seeds Fourth iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the fourth betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming two weeks after Apple released the third betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Are poppy seeds good for you? Consider the risks.
Poppy seeds aren't for everyone. Here's what these seeds are, how they can be good for you and why we still need to go easy on them.
How a science experiment to grow native plants on Copper’s slopes is inspiring collaboration in the ski industry
Katherine Riesberg, a graduate of Middle Park High School in Grand County, has been skiing since the age of two. Riesberg said her love for outdoor recreation is a big part of what led her...
How a science experiment to grow native plants on Copper’s slopes is inspiring collaboration in the ski industry
Katherine Riesberg, a graduate of Middle Park High School in Grand County, has been skiing since the age of two. Riesberg said her love for outdoor recreation is a big part of what led her...
How a science experiment to grow native plants on Copper’s slopes is inspiring collaboration in the ski industry
Katherine Riesberg, a graduate of Middle Park High School in Grand County, has been skiing since the age of two. Riesberg said her love for outdoor recreation is a big part of what led her...
Snapseed 4.1 for Android rolling out with ‘massively expanded’ RAW support
Google is beginning to roll out the first big update to Snapseed since the May redesign with version 4.1 for Android.
Novak Djokovic Made Wimbledon History At 39
Technically speaking, Novak Djokovic doesn't owe the tennis community anything at this stage in his career. And yet, the 39-year-old just keeps on rewriting history. Djokovic prevailed in an epic quarterfinal match against No. 3 seed Felix Auger-Aliassime at Wimbledon this Tuesday. The 24-time ...
What must Fery do to become Wimbledon semi-finalist?
Arthur Fery is bidding to become the fifth British man to reach the Wimbledon semi-finals in the Open era - here is how he can beat Italian 10th seed Flavio Cobolli.
Wimbledon recap Day 8: Alex de Minaur and the devastation that comes with elite sport
The No. 5 seed from Australia outlined how windows of opportunity at Grand Slams can quickly — and painfully — slam shut.
An Alicia Keys musical and more top Seattle theater to see this month
Alicia Keys’ musical joins Shakespeare, shadow puppets, seedy ’70s Seattleites and more on local stages this month.
Apple Seeds Third iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the third betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming two weeks after Apple released the second betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Apple veterans launch a $33 million fund for manufacturing tech
Omni Ventures will back pre-seed startups building AI, robotics, and automation tools for manufacturing.
Small flower farm’s business springs from a seed of trust
Every day at 5 a.m., while most of the world is asleep, Alicia Atwood sets out flower bouquets for sale in a small shop at the end of her driveway. The arrangements are priced at just $10, and her farm operates in a way almost no other business does -- through an honor system.
Stanford grads secure $11.6 million for women's hormone bracelet
Clair Health says today's wearables overlook women's health. Read the pitch deck behind its $11.6 million seed round.
Defending champion Swiatek & Rybakina out in Wimbledon shocks
Elena Rybakina becomes the highest seed to fall at Wimbledon so far in a straight-set third-round defeat by Elise Mertens.
We Could Seed Alien Life Elsewhere in the Universe—But We’ll Never Undo the Devastating Consequences, Scientists Caution
This “would be equivalent to a planetary invasion,” expert warns.
New to politics, Skovgard throws his hat in the race for U.S. Senate
CODY — In the Parable of the Sower, a sower throws seeds out in a field, and some are choked by thorns; others are eaten by birds; some fall onto
America’s next 250? A revival of civic virtues might hold the key.
Democracy requires civic engagement – and it can sometimes seem to be falling short. But the seeds of renewal are visible, from potluck dinners to youth programs.
McNeese SEED Center offering consultation services and small business growth roundtable
There are several upcoming opportunities for small businesses and entrepreneurs coming up at the McNeese SEED Center.
New to politics, Skovgard throws his hat in the race for U.S. Senate
CODY — In the Parable of the Sower, a sower throws seeds out in a field, and some are choked by thorns; others are eaten by birds; some fall onto
Cornell Yang Center for Wildlife Health awards seed funding to five conservation efforts around the globe
The CCF provides catalytic seed funding to spark pioneering applied research to advance wildlife conservation solutions. The fund prioritizes initiatives that improve the health of free-ranging wildlife and/or solve environmental problems via a One Health lens.
4 Sectors Attracting Seed Funding in Digital Entertainment
Digital entertainment is navigating a paradox. Overall venture capital flowing into gaming dropped sharply through 2025 and into 2026, yet seed-stage deal activity has remained surprisingly resilient across a handful of focused verticals
Houston Rockets Star Alperen Sengun Catches Stray From NBA Rookie
One of the NBA’s best young stars today is Houston Rockets center Alperen Sengun.The 23-year-old big man is already a two-time All-Star, averaging 20.4 points, 8.9 rebounds, 6.2 assists, 1.2 steals and 1.1 blocks last season. He helped the Rockets make the playoffs as the fifth seed.However, the Rockets suffered a disappointing exit at the […] The post Houston Rockets Star Alperen Sengun Catches Stray From NBA Rookie appeared first on HEAVY.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.